Warby Parker Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 53 out of 208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.17.In the medium term, the stock price is expected to remain stable.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
The current financial score of Warby Parker Inc is 6.64, ranking 132 out of 208 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 211.97M, representing a year-over-year increase of 11.19%, while its net profit experienced a year-over-year increase of 13.44%.
Key Metrics
The current valuation score of Warby Parker Inc is 7.95, ranking 50 out of 208 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 1519.43, which is 283.34% below the recent high of 5824.66 and 124.61% above the recent low of -373.97.
The current earnings forecast score of Warby Parker Inc is 7.86, ranking 112 out of 208 in the Healthcare Equipment & Supplies industry. The average price target is 22.00, with a high of 27.00 and a low of 18.00.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
The current price momentum score of Warby Parker Inc is 6.63, ranking 94 out of 208 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 25.54 and the support level at 17.65, making it suitable for range-bound swing trading.
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
The current institutional shareholding score of Warby Parker Inc is 10.00, ranking 1 out of 208 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 106.73%, representing a quarter-over-quarter increase of 10.68%. The largest institutional shareholder is The Vanguard, holding a total of 10.60M shares, representing 9.93% of shares outstanding, with 7.19% increase in holdings.
The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Warby Parker Inc is 4.30, ranking 107 out of 208 in the Healthcare Equipment & Supplies industry. The company's beta value is 2.05. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Warby Parker Inc’s latest ESG disclosure leads the Healthcare Equipment & Supplies industry, indicating outstanding, compliant performance across environmental management, social responsibility, and governance, which may help mitigate overall risk.
